chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash; The day after dose 2, it increases dramatically; to the point it looks like bock shot scars all over body below neck. Some spots are scarring; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent in response to consumer letter sent via follow-up letter and follow up received from a contactable consumer (patient).  A 22-year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 13Aug2021 16:00 (Lot number: FD8448F) at the age of 22 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, single; lot number: FA7484; via intramuscular route in arm; at 16:00), administration date: 23Jul2021, when the patient was 22 years old, for COVID-19 immunization, reaction(s): "Pityriasis Rosea". The following information was reported: RASH (non-serious) with onset 14Aug2021, outcome "not recovered", described as "Rash"; CONDITION AGGRAVATED (non-serious) with onset 14Aug2021, outcome "not recovered", described as "The day after dose 2, it increases dramatically"; RASH MACULAR (non-serious) with onset 14Aug2021, outcome "not recovered", described as "to the point it looks like bock shot scars all over body below neck. Some spots are scarring". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: patient received any other vaccine within 4 weeks, prior to the vaccination was reported as none. Patient medical history (including any illness at time of vaccination) reported as none. Not allowed to continue cream. Rash continues to grow exponentially. Clinical course: (with held) had 1 red spot of unknown nature 4 week before dose 1st of Pfizer. Within 2days these spots Increased dramatically. Diagnosed as Pityriasis Rosea. Started to subside in intensity before the week of 2nd dose. The day after dose 2 it increased dramatically in nature to the point it looks like bock shot scars all over body below neck. Some spots are scarring. Not good. It has not started to decrease in intensity at this point in time. Unfortunately, there was fear for any further vaccine.  No follow-up attempts are possible. No further information is expected.
Felt awful; Like hit with ton of bricks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 18Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: FEELING ABNORMAL (non-serious) with onset 19Mar2021, outcome "unknown", described as "Felt awful"; PAIN (non-serious) with onset 19Mar2021, outcome "unknown", described as "Like hit with ton of bricks".  Additional information: Pfizer vaccine 2nd dose on 18Mar2021. Felt 'awful' and 'like hit with ton of bricks' the following day. Awareness Date: 19Mar2021. Country of Occurrence. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a 52-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of injection site rash (1st dose received on 27th April 2018 and experienced adverse event refer linked case US2018171880). Concomitant products included BENADRYL. On 21st September 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site rash, injection site bruising, fatigue, muscle pain and shivering. On an unknown date, the outcome of the injection site rash was recovered/resolved and the outcome of the injection site bruising, fatigue, muscle pain and shivering were unknown. The reporter considered the injection site rash, injection site bruising, fatigue, muscle pain and shivering to be related to SHINGRIX. Additional details were provided as follows: The dose was not delivered for months. The patient experienced rash 2 inches below the injection site. The patient received the 1st dose and experienced some events. The patient experienced same reaction with dose 2, in additional to that the patient also experienced fatigue, muscle ache and shivering. Prior to 2nd dose, the patient took 2 doses of BENADRYL, as suggested by primary physician. The rash after 2nd dose disappeared quickly due to continued use of BENADRYL. The reporter was searching for phone calls this dose was very likely only dose available in the area. The VAERS details were updated.
GARDASIL 9 was given to a patient on October 9, 2020 after undergoing a temperature excursion; This spontaneous report has been received from an office manager referring to a patient of unknown age and gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.      On 09-OCT-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot #: S022598, expiration date: 25-FEB-2022, 0.5 milliliter; route was unknown) for prophylaxis. The vaccine was undergoing a temperature excursion of below 36 degrees Fahrenheit (16.5 degrees Fahrenheit) for 1 hour and above 47 degrees Fahrenheit (73 degrees Fahrenheit) for 4 hours (product storage error). There were no previous temperature excursions. There was no digital data logger involved. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: S022598; expirationdate: 25-FEB-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability.
Information has been received from a consumer concerning her 63 year old husband who on 28-JUL-2008 was vaccinated with ZOSTAVAX (Oka/Merck) (Lot#659672/0294X). Concomitant therapy included vitamins (unspecified). That same date, about 6 hours after getting ZOSTAVAX (Oka/Merck), the patient got a headache lasting 30 minutes. The next morning on 29-JUL-2008, the patient experienced dizziness and salivating (no nausea). He also felt sluggish. The patient's dizziness and salivating (no nausea) and felt sluggish persisted. No further information is expected.
I have developed High Blood pressure and I now take lisinopril medication and my HBP is not quite under control but better.
This spontaneous report as received from a pharmacist refers to a 50 year old patient of unknown gender with coronary artery disease and no drug reactions and allergies. On 07-SEP-2013 the patient was vaccinated with PNEUMOVAX23, 0.5 ml, intravenous (lot#, expiration date and frequency unknown). On 07-SEP-2013, a new nurse on orientation administered PNEUMOVAX23 intravenously. The patient was being treated for coronary artery disease. The nurse pulled up PNEUMOVAX23 and morphine in separate syringes, did not label, and gave PNEUMOVAX23 through the hep-lock. On 07-SEP-2013 the patient experienced flushing to his face, which resolved. No lab diagnostics and studies were performed. The patient didn't sought medical attention and was not given treatment for the event. Therapy with PNEUMOVAX23 was continued. Vital signs were done, within normal limits. Additional information has been requested.
He was ok, when he took his vaccine. He went swimming next week on Tuesday he developed a headache after swimming, I decided to take his BP and temp, his temp was normal and his blood pressure was low his heart rate was fast, it showed an irregular heart beat, I checked it with different monitor just in case it was off and it was the same. After a few days I decided to take him to the clinic and asked them to check if he is having an irregular heartbeat, he was showing low bp and a high heart rate. They sent him to ER they did an EKG, That Dr. sent him home, and the next few days I contacted his pediatrician and oncologist they told me to keep watching and monitoring his bp and heart rate. We saw a cardiologist, they found he doesn't have a consistent beat he was diagnosed Frequently Ventricular Ectopy.
Injection too high in the arm. Could not move arm in any direction. Limited mobility and lots of discomfort. Treated at urgent care with steroid and NSAID prescription.
Extreme fatigue Headache Muscle aches Pounding/ Irregular heartbeat Lightheaded
A mild rash appeared near my injection site 8 days after my injection-followed by sinus headache and  mild itchy skin all over (no rash or hives at all) for a few days. I have very sensitive skin and the shirt I had on seemed to irritate the area that day. I had no redness or any other symptoms-aside from some soreness the day after I got my vaccine. Not sure if it is necessary to report this as I did not require me to seek any medical assistance or had any disruption in my daily activities but thought it could help to share my information given the newness of the vaccine and evoloving experiences. Thank you.
"Slight tightness in my chest when I take deep breaths"; Aching joints; Aching muscles; Slight hearttburn; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT ("Slight tightness in my chest when I take deep breaths"), DYSPEPSIA (Slight hearttburn), ARTHRALGIA (Aching joints) and MYALGIA (Aching muscles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT ("Slight tightness in my chest when I take deep breaths"), DYSPEPSIA (Slight hearttburn), ARTHRALGIA (Aching joints) and MYALGIA (Aching muscles). At the time of the report, CHEST DISCOMFORT ("Slight tightness in my chest when I take deep breaths"), DYSPEPSIA (Slight hearttburn), ARTHRALGIA (Aching joints) and MYALGIA (Aching muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
When patient reported to pharmacy for the second dose in her series, she reported that she has had a bumpy rash across the thoracic region of her body since her first dose.  The rash has not subsided.  The patient has not sought any medical attention for evaluation of the rash.  The second dose was deferred until the patient is evaluated for the rash and any risks inherent in receiving the second Shingrix vaccination.
Patient had a 30 second syncopal event after administration of HPV vaccine. She did state that "this has happened before when I think about it too much afterwards".  EMS was activated, BP 85/55, patient refused to go with EMT to hospital for further evaluation.
This case was reported by a consumer (who was possibly a health care professional) and described the occurrence of injury in a female subject of unspecified age who was vaccinated with Havrix, for prophylaxis. On an unspecified date the subject received unspecified dose of Havrix. On 1 July 2005, at an unspecified time after vaccination with Havrix, the subject experienced an unspecified injury. At the time of reporting the outcome of the event was unspecified.
She Died. I was not informed of anything other than her death. Hospital records are conflicting. Tried to obtain medical records of shots given to my baby, but the doctor's office said "They don't have it".
three to four minutes later the patient was lying down on the floor said not feeling well, he said he is sick, he had nausea and then vomited on the floor. I had had him sit down on floor and told him to relax.  he said he never had to get two shots at once, and felt sick.  after few minutes he was well again and he went to restroom with his mother to wash his hand and face.  then they waited in the waiting room for 15 minutes and had water to drink felt better and left.
This spontaneous report was received from a pharmacist via a company representative and refers to a female patient of unknown age (pharmacist's mother). Patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 injection (dose, lot# and expiration date were not reported), intramuscularly for the prevention of pneumococcal disease. On an unknown date, the patient experienced injection site swelling and redness greater than expected. She did not seek medical attention. No treatment was given. The outcome of injection site swelling and redness was reported as recovered on an unknown date. The relatedness between the injection site swelling and redness and PNEUMOVAX 23 was not reported.
Left hip joint pain, painless, non-pruritic macular rash at site of injection.
Itching was so unbearable which spread from the injection site to the elbow and; Itching at injection site; Arm was painful; Arm was swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen), PRURITUS (Itching was so unbearable which spread from the injection site to the elbow and), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE PAIN (Arm was painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Historical condition reported).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE PAIN (Arm was painful). On an unknown date, the patient experienced PRURITUS (Itching was so unbearable which spread from the injection site to the elbow and). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm was swollen), PRURITUS (Itching was so unbearable which spread from the injection site to the elbow and), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE PAIN (Arm was painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products were not provided/unknown.   This case was linked to MOD-2021-231454 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Added reporter information.
about a week after the injection i started having a Crohn's flare. i called the Doctor over my clinical trial he advised me not to get the second shot and to fill this out and let you all know.
Patient currently hospitalized with profound bleeding and clotting, suspect dysfibrinogenemia, otherwise healthy without history of dysfibrinogenmeia
pt had a syncopal event post vaccination, was evaluated by ems and signed a refusal and left
This spontaneous report was received from a nurse refers to an unknown number patients of unknown age. On an unknown date, the patients were vaccinated with unknown number of doses with ROTATEQ, M004885 23-OCT-2017, M019708 25-OCT-2017, M025563 06-NOV-2017, M004890 10-NOV-2017 following a temperature excursion of 33F for 23 days. No adverse effects were reported. Additional information has been requested.
W/in 24 to 48hrs experienced n,v & diarrhea which spontaneously remitted in 24 hrs;
Headache, Myalgia, Fever, Chills Narrative:  Other Relevant History:
Fever x 2 days. Muscle pain (R) thigh. Redness and swelling (R) thigh with bruise.
Information has been received from a company representative concerning 3 females who were vaccinated with a dose of GARDASIL. It was reported that after receiving a dose (unspecified whether first, second or third dose) the patients fainted. It was reported that one of the patients broke her tooth when she fell. The patient's status was reported as recovered. Attempts are being made to obtain identifiable information about the individual patients. Additional information has been requested.
Really bad allergies it what it felt like. Constant sneezing and everything was achy and I coughed really bad. I tried to take Sudafed and Zyrtec but it didn't get better. I went to the clinic finally. I went on Friday. Got on an antibiotic for 10 days, Zyrtec and Flonase. I am really tired. I haven't been able to work out for my second week now. I tried to swim on Monday but the next day it felt me like I was beat down. My coughing symptoms are getting a lot better. I'm week but I'm getting better. Rocephin - they gave me this shot at the clinic, as well. In March 2021 - symptoms with my long standing condition was worsened at that time with my prostrate. I was on antibiotic  - Doxycycline for a month. For that. That helped. Had to see Urologist - a lot of inflammation and rectal burning. Some of this keeps coming back and take Fosfomycin - the last time I was on it was July 20-23, for three days. I start that when it starts acting up again so it doesn't flare up again. It had been about 7 weeks before that that I had taken it. Pelvic discomfort too - I am trying to get on with an Infectious doctor to see if that will help. Noticed I was getting a lot of gas on my bottom. Antibiotics can help. I haven't been sleeping well either for a long time. I haven't been sleeping much - some of that may have started before the vaccine.
Major site pain at Lt deltoid, started on 9/20/19 and went away approx. 2-3 days after, rated pain as 6/10 at most intense level.   Major Rt hip pain, started on 9/25/19, painful to sit, bear weight on it when laying on R side, and moving it in certain positions due to it freezing up. Lower back pain with spasms and cramping intermittently while sitting or lying down, similar to childbirth spasms and cramping.   Right hip & lower back pain symptoms resolved spontaneously around 4 days after 9/25/19.
4 inch by 3 inch red, swollen, very itchy skin rash under the injection site on the left arm.
Headache/Migraine for 6 weeks treated at 2 weeks with 60 mg Torodol- headache went away for 2 days treated at 6 weeks with 30 mg Torodol, then a course of steroids, headache completely resolved
Joint and muscle aches, fatigue, soreness at injection site. Flu-like symptoms.
Pain at the injection site; Body ache; Pain around the lower back; Pain the legs; Chills throughout the night very uncomfortable; Felt feverish; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site), PAIN (Body ache), BACK PAIN (Pain around the lower back), PAIN IN EXTREMITY (Pain the legs) and CHILLS (Chills throughout the night very uncomfortable) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site), PAIN (Body ache), BACK PAIN (Pain around the lower back), PAIN IN EXTREMITY (Pain the legs), CHILLS (Chills throughout the night very uncomfortable), PYREXIA (Felt feverish) and FATIGUE (Tiredness). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site), PAIN (Body ache), BACK PAIN (Pain around the lower back), PAIN IN EXTREMITY (Pain the legs), CHILLS (Chills throughout the night very uncomfortable), PYREXIA (Felt feverish) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment medications were reported. no concomitants were provided.
Pt started having bloating, weight loss, abdominal pain,  found to have 14cm ovarian cancer mass
This spontaneous report as received from a health care worker reported also as medical assistant (CMA) refers to a 2 months old patient of unknown gender. It was reported that on unknown date pediatric patient came in the office for immunization. The patient was supposed to received ROTATEQ (dose, lot # and route unspecified), PEDIARIX (dose, lot# and route unspecified) and PEDVAXHIB. It was reported that the patient was inadvertently administered ROTATEQ, RECOMBIVAX HB (dose, lot # and route unspecified); PEDVAX HIB has not yet been administered. No adverse effects were reported.  Additional information is not expected.
Vaccination site rash; Vaccination site Itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE PRURITUS (Vaccination site Itchy) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE PRURITUS (Vaccination site Itchy). At the time of the report, VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE PRURITUS (Vaccination site Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
After the injection, he was crying and then momentarily stopped breathing and went completely limp. He did not move or breathe for at least 20 seconds and when he woke up, he was drenched in sweat, clammy, and confused. We are discontinuing the shots.
5/8/22: Patient reports vasculitis, nausea, joint, & muscle pain. Knees, wrists, ankles. Muscle pain & joint pain are continuing to spread as of today, 6/2/22.  Patient sought medical treatment on 5/14/22. Admitted to hospital on 5/31/22. Still admitted as of today, 6/2/22.
Began with chills and slight fever (100.5) within 24 hours.  By day 3 began to feel dizzy.  Diagnosed with Vertigo on Day 4. Ten days later the dizziness still occurs.